Psychedelic mushrooms, containing the active ingredient psilocybin, have shown remarkable potential in treating various ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

Psychedelic therapy is set to launch in Colorado this spring, with the state considering licenses for healing centers, ...

Psychedelics produce fast and persistent antidepressant effects and induce neuroplasticity resembling the effects of clinically approved antidepressants. Psychedelics produce fast and persistent ...

A psychedelic drug is being tested as a novel way to reduce ... There’s some early evidence that single use in clinical settings can be helpful to treat depression or reduce smoking or opioid ...

A psychedelic drug is being tested as a novel way to reduce problematic alcohol consumption, in an ongoing study led by UCL ...

Psilocybin-assisted therapy induced positive personality changes in adults with alcohol use disorder, which may help to ...

Psilocybin-assisted psychotherapy (PAP) has been shown to potentially have mental health benefits for patients with cancer, ...

Psilocybin, the active compound in psychedelic mushrooms, was legalized by Colorado voters in 2022. But according to two of ...

New research involving ketamine continues show that having a mystical experience is key to the effectiveness of psychedelic ...

A state bill that could allow for synthetic psilocybin to be prescribed in Colorado cleared a key committee hearing on ...